Evidence map›Paper›PMID 29970083›Full record

ArticleRespiratory research2018

Impact of immunization against OxLDL on the pulmonary response to cigarette smoke exposure in mice.

Maude Talbot, Mélanie Hamel-Auger, Marie-Josée Beaulieu, Morgan Gazzola, Ariane Lechasseur, Sophie Aubin, Marie-Ève Paré, David Marsolais, Ynuk Bossé, Mathieu C Morissette

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Maude TalbotFaculty of Medicine, Université Laval, Quebec City, Canada.
Mélanie Hamel-AugerFaculty of Medicine, Université Laval, Quebec City, Canada.
Marie-Josée BeaulieuQuebec Heart and Lung Institute - Université Laval, 2725 Chemin Sainte-Foy, Quebec City, G1V 4G5, Canada.
Morgan GazzolaFaculty of Medicine, Université Laval, Quebec City, Canada.
Ariane LechasseurFaculty of Medicine, Université Laval, Quebec City, Canada.
Sophie AubinQuebec Heart and Lung Institute - Université Laval, 2725 Chemin Sainte-Foy, Quebec City, G1V 4G5, Canada.
Marie-Ève ParéQuebec Heart and Lung Institute - Université Laval, 2725 Chemin Sainte-Foy, Quebec City, G1V 4G5, Canada.
David MarsolaisQuebec Heart and Lung Institute - Université Laval, 2725 Chemin Sainte-Foy, Quebec City, G1V 4G5, Canada.
Ynuk BosséQuebec Heart and Lung Institute - Université Laval, 2725 Chemin Sainte-Foy, Quebec City, G1V 4G5, Canada.
Mathieu C MorissetteQuebec Heart and Lung Institute - Université Laval, 2725 Chemin Sainte-Foy, Quebec City, G1V 4G5, Canada. mathieu.morissette@criucpq.ulaval.ca.
Université Laval · CA

Funding

Faculty of Medicine, Université Laval N/A
6 · The paper itself

Abstract

backgroundCigarette smoke exposure can affect pulmonary lipid homeostasis and cause a progressive increase in pulmonary antibodies against oxidized low-density lipoproteins (OxLDL). Similarly, increased anti-OxLDL antibodies are observed in atherosclerosis, a pathology also tightly associated with smoking and lipid homeostasis disruption. Several immunization strategies against oxidized lipid species to help with their clearance have been shown to reduce the formation of atherosclerotic lesions. Since oxidized lipids are generated during cigarette smoke exposure, we investigated the impact of a prophylactic immunization protocol against OxLDL on the pulmonary effects of cigarette smoke exposure in mice.

methodsMice were immunized systemically with a mixture of human OxLDL (antigen source) and AddaVax (adjuvant) or PBS alone prior to the initiation of acute (2 week) or sub-chronic (8 weeks) cigarette smoke exposure protocols. Anti-OxLDL antibodies were measured in the bronchoalveolar lavage (BAL) fluid and serum by direct ELISA. Pulmonary impacts of cigarette smoke exposure and OxLDL immunization were assessed by measuring BAL inflammatory cells, lung functions, and changes in lung structure and gene levels of matrix/matrix-related genes.

resultsImmunization to OxLDL led to a marked increase in circulating and pulmonary antibodies against OxLDL that persisted during cigarette smoke exposure. OxLDL immunization did not exacerbate or reduce the inflammatory response following acute or sub-chronic exposure to cigarette smoke. OxLDL immunization alone had effects similar to cigarette smoke exposure on lung functions but OxLDL immunization and cigarette smoke exposure had no additive effects on these parameters. No obvious changes in lung histology, airspace or levels of matrix and matrix-related genes were caused by OxLDL immunization compared to vehicle treatment.

conclusionsOverall, this study shows for the first time that a prophylactic immunization protocol against OxLDL can potentially have detrimental effects lung functions, without having additive effects over cigarette smoke exposure. This work sheds light on a complex dynamic between anti-OxLDL antibodies and the pulmonary response to cigarette smoke exposure.

Indexed as

Administration, InhalationAnimalsCigarette SmokingFemaleHumansImmunizationLipoproteins, LDLMiceMice, Inbred BALB CRespiration DisordersSmokeLipoproteins, LDLoxidized low density lipoproteinSmoke

Identifiers

PMID29970083
PMCPMC6029023
OpenAlexW2810947127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.